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Escherichia coli O26 and O157 have similar overall 
prevalences in cattle in Scotland, but in humans, Shiga 
toxin–producing E. coli O26 infections are fewer and clinically 
less severe than E. coli O157 infections. To investigate 
this discrepancy, we genotyped E. coli O26 isolates from 
cattle and humans in Scotland and continental Europe. The 
genetic background of some strains from Scotland was 
closely related to that of strains causing severe infections 
in Europe. Nonmetric multidimensional scaling found an 
association between hemolytic uremic syndrome (HUS) 
and multilocus sequence type 21 strains and confi rmed 
the role of stx2 in severe human disease. Although the 
prevalences of E. coli O26 and O157 on cattle farms in 
Scotland are equivalent, prevalence of more virulent strains 
is low, reducing human infection risk. However, new data on 
E. coli O26–associated HUS in humans highlight the need 
for surveillance of non-O157 enterohemorrhagic E. coli and 
for understanding stx2 phage acquisition.
Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) are gastrointestinal 
pathogens associated with asymptomatic carriage and 
human diseases ranging from mild diarrhea to hemorrhagic 
colitis and hemolytic uremic syndrome (HUS) (1). 
Worldwide, EHEC serogroup O157 strains are responsible 
for most human Shiga toxin–producing E. coli (STEC) 
infections (2). However, recent outbreaks in Germany (3) 
and the United States (4) have highlighted the increasing 
role of other Shiga toxin–producing serogroups (termed 
non-O157 strains) in causing human disease.
The pathogenesis of EHEC strains is associated with 
production of Shiga toxins expressed from lysogenic 
bacteriophages in the EHEC genome. There are 2 
predominant classes of Shiga toxins (1 and 2), each 
encoded from 2 genes, stxAB, with the genotypes simplifi ed 
to stx1 or stx2 in this study. Whereas EHEC is regarded as 
an emerging zoonotic pathogen, the related EPEC strains 
cause diarrhea, especially in infants in developing countries 
(1).
EPEC and EHEC express a type III secretion (T3S) 
system that translocates multiple effector proteins into 
host cells and manipulate host innate responses, which 
are needed for colonization (5–7). The T3S system is 
central to the formation of attaching and effacing lesions 
on the intestinal epithelium that requires the bacterial outer 
membrane protein intimin (encoded by eae) and the secreted 
bacterial protein—the translocated intimin receptor (Tir)—
that is injected into the host cell. Studies of EPEC and 
EHEC O157 show that these pathogens trigger different 
actin polymerization pathways respectively involving Tir 
cytoskeleton coupling proteins (tccP or tccP2) (5). The 
formation of attaching and effacing lesions is needed for 
bacterial colonization by EHEC O157 and EHEC O26 in 
cattle. However, Shiga toxin (Stx) is the principal factor 
responsible for severe human illness, including HUS (8). 
Strains with stx2 alone appear more strongly associated 
with HUS than do strains with only stx1 (8–10). These 
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observations have been supported by mouse (11) and 
primate models (12).
Among non-O157 EHEC, Stx-producing E. coli O26 
also causes human disease (13–15) and has been isolated 
from livestock (16). However, unlike EHEC serogroup 
O157, it may be pathogenic for both cattle and humans 
(17). Although the origin of human E. coli O26 infections 
is rarely identifi ed (18), evidence exists of person-to-person 
spread (19) and foodborne transmission (20). Furthermore, 
because EHEC O26 has been isolated from the feces of 
cattle and other animals (16,21,22), potential exists for 
direct and indirect zoonotic transmission to humans (20).
In the United Kingdom, Stx-producing human E. coli 
O26 infections are usually uncommon and not clinically 
severe. Most identifi ed EHEC infections are associated 
with serogroup O157, and incidence rates in Scotland 
are among the highest, compared with rates in countries 
with comparable surveillance (23). In contrast with human 
infection rates, farm and animal prevalence of E. coli 
serogroups O26 and O157 are similar in Scotland (21).
Our fi rst objective was to identify the cause of the 
disparity between the incidence of E. coli O157 and O26 
infections among humans in Scotland by examining 
the natural heterogeneity among serogroup O26 strains 
and reexamining their prevalence in cattle. As a second 
objective, we used different molecular techniques to 
compare the relationships between E. coli O26 isolates 
recovered from humans and cattle.
Methods
Bacterial Isolates
All bacterial isolates used in this research are shown 
in Table 1. All isolates from cattle were collected in 
parallel with a prevalence study of E. coli O157 in cattle 
in Scotland, conducted during 2002–2004 (21). Fecal 
samples were obtained from cattle on 338 farms to test 
for non-O157 E. coli strains, including serogroup O26, as 
described by Pearce et al. (21). Human E. coli O26 isolates 
came from collections within the United Kingdom, Ireland, 
and continental Europe.
PCR for Virulence Genes
Genes encoding stx1, stx2, eae, and hlyA were detected 
by using multiplex PCR (24). Possession of the locus of 
enterocyte effacement (LEE) pathogenicity island was 
confi rmed by PCR screening for sepL. Genes encoding 
tccP and tccP2 were detected with PCR by using universal 
primer pair univtccP/tccP2-F and tccP-R (25). Primers and 
PCR conditions used in this study are listed in Table 2.
Pulsed-fi eld Gel Electrophoresis
We performed pulsed-fi eld gel electrophoresis (PFGE) 
on 187 isolates (33 from humans and 154 from cattle) 
(Table 1) by using the method of Willshaw et al. (26), 
standardized by the Scottish E. coli O157/VTEC Reference 
Laboratory (SERL; Edinburgh, UK) and the Laboratory 
of Gastrointestinal Pathogens (Colindale, UK). A phage 
λ ladder (48.5 kb) was used as a DNA size standard, 
and gels were run with a linearly ramped switch time of 
5–50 s applied for 38 h at a voltage of 5.4 V/cm and an 
included angle of 120°. PFGE profi les were analyzed by 
using BioNumerics (version 3.0) software (Applied Maths, 
Kortrijk, Belgium). The degree of similarity between 
profi les was determined by the Jaccard coeffi cient, and 
dendrograms were generated by using the unweighted pair 
group method with arithmetic mean with 1.3% tolerance 
and 1% optimization settings.
Multilocus Sequence Typing
We performed multilocus sequence typing (MLST) 
on 63 isolates (30 from humans and 33 from cattle) (Table 
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Table 1. Source of Escherichia coli O26 isolates and sample sizes for the various statistical analyses, Scotland* 
Source Country of origin Analyses No. isolates Clinical information 
Bovine† Scotland Prevalence 249 NR 
Bovine† Scotland PFGE 154 NR 
Bovine† Scotland MLST 33 NR 
Human‡ Scotland PFGE 12 NK 
Human‡ Scotland MLST 11 D (n = 8); BD (n = 2); NK (n = 1) 
Human§ England PFGE 4 NK 
Human§ Ireland PFGE 11 NK 
Human§ Belgium PFGE 2 NK 
Human§ Sweden PFGE 3 NK 
Human§ Italy PFGE 1 NK 
Human¶ Italy MLST 5 HC (n = 1); HUS (n = 4) 
Human# Germany MLST 14 D (n = 6); HUS (n = 8) 
*NR, not relevant; PFGE, pulsed-field gel electrophoresis; MLST, multilocus sequence typing; NK, not known; D, diarrhea; BD, bloody diarrhea, HC, 
hemorragic colitis; HUS, hemolytic uremic syndrome. Where appropriate, the number of isolates from each clinical designation is provided. 
†Isolated 2002–2004 (21).
‡L.J. Allison, Scottish E. coli O157/VTEC Reference Laboratory, Edinburgh, UK; isolated 2002–2003. 
§H. Smith, Laboratory of Gastrointestinal Pathogens, Colindale, UK. The years isolated are unknown. 
¶A. Caprioli, Instituto Superiore di Sanità, Rome, Italy. The years isolated are unknown. 
#H. Karch, University of MĦnster, MĦnster, Germany; isolated 1994–2000. 
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1) by using a method similar to that of Wirth et al. (27). 
Internal fragments of 7 housekeeping genes (adk, fumC, 
gyrB, icd, mdh, purA, and recA) were sequenced, and the 
allele numbers and sequence types (STs) were assigned in 
accordance with the E. coli MLST database (http://mlst.
ucc.ie/mlst/dbs/Ecoli). The T3S system of E. coli O26 
is encoded on the LEE, and this region was originally 
sequenced from E. coli O26 isolate 413/89–1 (GenBank 
accession no. AJ277443). From this sequence, primers were 
designed to amplify espA encoding the main translocation 
fi lament protein of the T3S system and a 644-bp region 
(5082–5726) including the promoter controlling expression 
of the fi rst LEE operon (LEE1) (Table 2). Sequence data 
for espA and the LEE1 promoter region were compared by 
using ClustalX (www.clustal.org). Each unique sequence 
was given a different allele number assigned in the order in 
which they were discovered.
Data Management and Statistical Analyses
Prevalence of E. coli O26
E. coli O26 isolated from cattle are more heterogeneous 
than E. coli O157 with respect to the presence of stx and eae 
(Figure 1). Therefore, we determined the prevalence of E. 
coli O26 for 4 different groups with potential differences in 
virulence: 1) all E. coli O26, similar to Pearce et al. (21); 2) 
stx1+; 3) stx1+stx2+; and 4) stx2+eae+. Farm-level and fecal 
pat–level prevalences were calculated by using the method 
of Pearce et al. (28). SAS version 9.1.3 (SAS Institute, 
Cary, NC, USA) was used to fi t generalized linear mixed 
models and to generate bootstrap-based estimates of key 
parameters. Excel 2000 (Microsoft Corporation, Redmond, 
WA, USA) was used to implement a Latin hypercube 
sampling to convert results from generalized linear mixed 
models into prevalence taking into account random effects 
(29).
PFGE Analysis
Differences between isolates from humans and 
cattle were evaluated by assigning isolates to statistically 
distinct groups. The methods used are described in (30). 
Group membership was determined by estimating an 
optimum cutoff value using dendrogram-based distances. 
Statistical support for each group was evaluated by using 
the cophenetic correlation. The statistical signifi cance of 
the cophenetic correlation was evaluated by using a Mantel 
test. Program zt (31) was used with 1,000 simulations, 
and the probability of the observed cophenetic correlation 
occurring by chance was <5% for groups of isolates 
regarded as statistically distinct.
A subset of 41 isolates from Scotland (8 from humans 
and 33 from cattle) were included in the MLST and PFGE 
analyses. The PFGE data for 3 isolates from humans 
were missing and therefore could not be included in the 
comparison. Agreement between these 2 techniques was 
examined.
Nonmetric Multidimensional Scaling
To identify patterns in data associated with the clinical 
severity of infection in humans, we used nonmetric 
multidimensional scaling (NMS) to analyze all genotype 
characteristics measured. PC-ORD software version 6.03 
(MjM Software Design, Gleneden Beach, OR, USA) was 
used. The main matrix was created from the following 
isolate data: MLST type (ST, ST complex), tccP and 
tccP2, Stx status, hlyA, eae, LEE, and sequence upstream 
region of LEE1. A second matrix that used isolate data and 
an indicator of clinical severity was also created. Isolates 
were separated into 2 groups: 1) HUS and those associated 
with HUS and 2) non-HUS, including those from diarrhea, 
bloody diarrhea, and hemorrhagic colitis. The grouping 
was chosen because HUS has clearly identifi able clinical 
characteristics and is a reliable indicator of severe illness.
We used NMS with a Euclidian distance measure 
after standardizing each variable by division by its 
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Table 2. Primers and PCR conditions for Escherichia coli O26, Scotland 
Primer name Primer sequence, 5c o 3c Target gene Annealing Amplicon size, bp Reference 
stx1F 
stx1R 
ATAAATCGCCATTCGTTGACTAC 
AGAACGCCCACTGAGATCATC 
stx1 60°C,45 s 180 (24)
stx2F 
stx2R 
GGCACTGTCTGAAACTGCTCC 
TCGCCAGTTATCTGACATTCTG 
stx2 60°C,45 s 255 (24)
eaeAF 
eaeAR 
GACCCGGCACAAGCATAAGC 
CCACCTGCAGCAACAAGAGG 
eae 60°C,45 s 384 (24)
hlyAF 
hlyAR 
GCATCATCAAGCGTACGTTCC 
AATGAGCCAAGCTGGTTAAGCT 
hlyA 60°C,45 s 534 (24)
sepLF 
sepLR
GCTAAGCCTGGGATATCGC 
ACAATCGATACCCGAGAAGG 
sepL 60°C,45 s 725 This study 
univ tccP/tccp2-F 
tccP-R 
GTAAAAACCAGCTCACCTTTTTC 
TCACGAGCGCTTAGATGTATTAAT 
tccp
tccP2 
64°C,60 s Variable (25)
espAF
espAR
CCTTCTCGGGTATCGATTGTCG 
CAGAGGGCGTCACTAATGAGTG 
espA 58°C,60 s 1012 This study 
LEE1promF 
LEE1promR 
CGAATGGTACGGTTATGCGGG 
GCTCTCGCAGTCGCTTTGCTTCC 
LEE1 58°C,60 s 645 This study 
RESEARCH
standard deviation. The dimensionality of the dataset was 
determined by plotting an inverse measure of fi t (“stress”) 
to the number of dimensions. Optimal dimensionality was 
based on the number of dimensions with the lowest stress. 
A 3- dimensional solution was shown to be optimal. We 
performed several NMS runs to ensure that the solution 
was stable and probably represented a confi guration with 
the best possible fi t. For each NMS run, we used 500 
iterations with random starting coordinates. The overall 
signifi cance of the difference between HUS and non-HUS 
groups was assessed by using multiresponse permutation 
procedures (32).
Results
Prevalence in Cattle
Of the 338 farms visited, 68 were positive for E. coli 
O26 (mean prevalence 20.1%, exact binomial 95% CI 16.0–
24.8); these 68 farms were evenly distributed across 
Scotland (Figure 2, panel A). Farms were classifi ed by 
their isolates’ virulence groups: stx–, stx1+, and stx1+stx2+. 
No farm had stx2+ only strains. Farms with stx– isolates 
clustered in southern Scotland. Farms that were stx1+ were 
fairly evenly distributed, but those with stx1+stx2+ isolates 
were found mainly in the northeast (Figure 2, panel B). 
Analysis of the farms grouped according to their Scottish 
animal health district (21) signifi cantly supported this 
observation (p = 0.005). No seasonal differences were 
observed (p = 0.59).
The adjusted mean overall prevalence of E. coli O26 
was 0.22 (95% CI 0.18–0.27) and 0.046 (95% CI 0.031–
0.062), respectively (Table 3). However, the adjusted mean 
prevalences for farms and fecal pats of stx2+eae+ E. coli 
O26 were lower at 0.05 (0.03–0.09) and 0.004 (0.001–
0.007), respectively.
PFGE Genotyping
PFGE profi les of the 187 E. coli O26 isolates from 154 
cattle and 33 humans were compared (online Technical 
Appendix Figure 1, wwnc.cdc.gov/EID/pdfs/11-1236-
Techapp.pdf). This comparison identifi ed 4 groups 
comprising 5, 19, 142, and 16 isolates, which all included 
E. coli O26 isolates from cattle and humans. The 4 groups 
are characterized by statistically signifi cant cophenetic 
correlations ranging from 0.807 to 0.945. Isolates from 
groups 2 and 4 were mainly stx–, whereas groups 1 and 
3 were mainly stx+. Five isolates were not assigned to a 
group. All of the stx+ isolates from outside Scotland were 
in group 2, along with the 5 stx+ isolates from Scotland. 
The remaining isolates from Scotland were in group 1 (2 
isolates), 2 (3 isolates), and 4 (1 isolates).
We compared PFGE profi les of the 41 E. coli O26 
isolates from 33 cattle and 8 humans. PFGE grouping 
correlated strongly with MLST ST (online Technical 
Appendix Figure 2). PFGE was more discriminative than 
MLST because each ST was represented by >1 PFGE 
pattern.
MLST Analysis
Irrespective of source, most isolates had a close 
genetic background (Table 4). Ninety percent of all isolates 
were either ST21 or ST29, both belonging to ST complex 
29 and differing by 1 nt in the adk locus. Most isolates from 
continental Europe were ST21 (74%) and stx2+ (53%). 
Considerably fewer isolates from humans in Scotland 
were ST21 (36%) and stx2+ (18%). Other differences 
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Figure 1. Isolates of Escherichia coli O26 (A; n = 249) and O157 (B; 
n = 507), collected from a 2002–2004 fi eld survey, that illustrate the 
differences between the 2 serogroups from Scotland with reference 
to the presence or absence of Shiga toxin gene (stx1 and stx2) and 
the eae gene. 
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between Scotland and continental Europe were related to 
the relative absence of tccP2 in isolates from Scotland and 
the presence of different alleles upstream of LEE (Table 
4). Isolates from cattle were genotypically more similar to 
those from humans from Scotland than from continental 
Europe (Table 4), except for the proportion of isolates that 
were ST21 and stx2+. This similarity may be explained by 
the fact that the isolates analyzed from cattle (33 [13%] of 
249) were not a random sample of all isolates from cattle 
but were selected on their virulence properties (i.e., stx+ 
and eae+) to assess their potential to cause human infection 
rather than to provide a direct comparison with isolates 
from humans in Scotland.
Disease Severity Association
Before NMS analysis, 3 isolates were excluded because 
of missing data. ST complex, LEE, tccP, and eae were 
removed because no variation existed in the data (Table 
4). The fi nal matrix comprised 5 variables and 27 isolates. 
The fi nal NMS solution was 3-dimensional and explained 
90.8% of the variation in clinical severity and explained 
more variation than expected by chance (Monte Carlo, p = 
0.008). Final stress for the 3-dimensional solution was 8.53 
with no real risk for drawing false associations (32), and 
the fi nal instability was 0 with 53 iterations.
The results of the NMS models are shown in joint 
graphs (Figure 3, panel A) and 3-dimensional ordination 
graphs (Figure 3, panel B) of the distance between sample 
units, which approximates dissimilarity in clinical severity. 
Where appropriate, R package version 2.12.1 (33) was used 
to add 80% confi dence ellipsoids to discriminate between 
groups of interest. Variables used in the NMS analysis 
are shown as vectors; the direction indicates positive and 
negative correlation (Figure 3, panel A). Although some 
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Figure 2. Location of farms sampled in 2002–2004 fi eld survey for Escherichia coli O26, Scotland. A) Farms that were positive for E. coli 
O26 are shown in red; farms negative for E. coli O26 are shown in green. B) The positive farms were subdivided according to differences 
in virulent properties of E. coli O26 (farm status) based on the possession of stx. Farms were designated as stx– (blue), stx1+ (yellow), or 
stx1+stx2+ (red).
Table 3. Farm-level and fecal pat–level prevalence of Escherichia coli O26, Scotland* 
E. coli O26 status 
Farms, n = 338 Fecal pats, n = 6,086 
No.
positive 
Observed
prevalence
Adjusted prevalence 
(95% CI) 
No.
positive 
Observed
prevalence
Adjusted prevalence 
(95% CI) 
E. coli O26* 68 0.20 0.22 (0.18–0.27) 249 0.041 0.046 (0.031–0.062) 
stx+ E. coli O26 38 0.11 0.12 (0.09–0.16) 122 0.020 0.020 (0.012–0.029) 
stx1 + stx2 + E. coli O26 13 0.04 0.06 (0.031–0.09) 97 0.016 0.004 (0.001–0.008) 
stx1 + stx2 + eae + E. coli O26 12 0.04 0.05 (0.03–0.09) 24 0.004 0.004 (0.001–0.007) 
*Minor differences in the farm-level prevalence estimates for E. coli O26 between Pearce et al. (21) and this study resulted from use of different statistical 
models. Pearce et al. (21) aimed to provide national prevalence estimates; thus, weighted estimates of mean prevalence were generated that accounted 
for the fractions of the national herd found in different Animal Health Districts (AHDs). By contrast, we reported the mean of the sample collected in a 
stratified fashion across the AHDs. Because there were only relatively small differences in mean prevalence in the different AHDs, the effect on the 2 
means is negligible and the effect on the standard errors relatively small. 
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overlap exists, the difference between HUS and non-
HUS groups was statistically signifi cant (multiresponse 
permutation procedures, p = 0.007) (Figure 3, panel B). 
HUS was associated with ST21 and stx2, whereas non-HUS 
cases were associated with ST29 and the absence of stx2. 
The hlyA gene was not associated with either condition 
because 69% of non-HUS isolates possess hlyA and 67% 
of HUS isolates possess hlyA (Figure 3, panel A).
Discussion
Although Stx-producing E. coli O26 is a major cause 
of HUS in continental Europe, human infection with this 
pathogen is uncommon in Scotland and has resulted in less 
severe illness. In contrast, E. coli O157 is a major cause of 
human infections and HUS (1). Previous reports of a high 
prevalence of E. coli O26 in cattle (21) do not appear to be 
matched by a high level of infection in humans. Our fi rst 
objective was to determine whether this discrepancy could 
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Table 4. Results of genotypic characterization by MLST and the presence of virulence genes for Escherichia coli O26 isolates, 
Scotland*
Genotypic characterization 
No. (%) isolates from humans, n = 30 No. (%) isolates from cattle, 
Scotland, n = 33 Scotland Germany/Italy 
MLST    
 ST    
  21 4 (36.4) 14 (73.7) 22 (66.6) 
  29 4 (36.4) 5 (26.3) 9 (27.3) 
  Other 3 (27.2) 0 2 (6.1) 
 ST complex†    
  29 10 (90.9) 19 (100.0) 31 (93.9) 
  10 1 (9.1) 0 2 (6.1) 
espA‡    
  Allele 1 9 (81.8) 19 (100.0) 31 (100.0) 
  Other 1 (9.1) 0 0 
  ND 1 (9.1) 0 0 
 Upstream of LEE1§    
  Allele1 2 (18.2) 14 (73.7) 7 (21.2) 
  Allele2 5 (45.4) 5 (26.3) 20 (60.6) 
  allele3 0 0 1 (3.0) 
  allele4 1 (9.1) 0 3 (9.1) 
  allele5 1 (9.1) 0 0 
  allele6 1 (9.1) 0 0 
  ND 1 (9.1) 0 2  (6.1) 
Presence of virulence genes    
 stx    
stx– 6 (54.5) 4 (21.1) 7 (21.2) 
stx1 + 3 (27.3) 5 (26.3) 16 (48.5) 
stx2+ 2 (18.2) 10 (52.6) 10 (30.3) 
Eae¶    
  Absent 1 (9.1) 0 2 (6.1) 
  Present 10 (90.9) 19 (100.0) 31 (93.9) 
sepL#    
  Absent 1 (9.1) 0 2 (6.1) 
  Present 10 (90.9) 19 (100.0) 31 (93.9) 
hlyA**    
  Absent 3 (27.3) 7 (36.8) 6 (18.2) 
  Present 8 (72.7) 12 (63.2) 27 (81.8) 
tccP††    
  Absent 11 (100.0) 19 (100.0) 33 (100.0) 
  Present 0 0 0 
tccP2††    
  Absent 6 (54.5) 2 (10.5) 16 (48.5) 
  Present 5 (45.5) 17 (89.5) 17 (51.5) 
*MLST, multilocus sequence typing; ST, sequence type; ND, not determined; stx, Shiga toxin; +, stx gene present; –, stx gene absent. LEE1 encodes the 
first operon of the locus of enterocyte effacement (LEE) and the 644-bp region sequenced includes the promoter for this operon amplified using the 
defined LEE primer pair in Table 2. 
†The ST and ST complex were assigned in accordance with the E. coli MLST database (http://mlst.ucc.ie/mlst/dbs/Ecoli). 
‡espA encodes for the surface-associated protein, espA. The allele numbers at each loci were assigned in the order in which they were discovered. 
§Six different sequences were discovered for the region upstream of LEE1 in the E. coli O26 isolates. Approximately 644 bp of sequence data were 
determined, and all sequence variation between the E. coli O26 alleles occurs within a 91-bp region upstream of LEE1 in the region where regulators act 
in E. coli O157:H7. The allele numbers at each locus were assigned in the order in which they were discovered. 
¶eae, gene that encodes intimin. 
#sepL, gene confirming the presence of LEE pathogenicity island. 
**hlyA, enterohemolysin. 
††tccP/tccP2, genes encoding Tir-cytoskeleton coupling protein and Tir-cytoskeleton coupling protein 2, which are used in actin polymerization and 
subsequent attaching and effacing lesion formation. 
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be explained by the natural heterogeneity in strains by 
examining virulence determinants associated with serious 
human disease in strains recovered from cattle in Scotland.
The overall percentage of farms on which E. coli 
shedding was detected and the overall proportion of fecal 
pats positive were comparable for both organisms, but for 
E. coli O26, the farm and pat-level prevalence becomes 
smaller as the carriage of the virulence determinants eae 
and stx are taken into account (Figure 4). In contrast, the 
prevalence of virulent strains of E. coli O157 (stx+eae+) is 
not smaller. Thus, because there are fewer virulent strains 
at farm and animal levels, the risk for human illness is 
expected to be much lower for E. coli O26 than for E. coli 
O157 in Scotland.
Our second objective was to determine the genetic 
relationship of strains from different sources. PFGE 
characterization demonstrated that PFGE profi les of 
isolates from humans differed from those from cattle. 
This result was expected in the absence of a demonstrable 
epidemiologic link. However, human strains are widely 
distributed among groupings of isolates from cattle. 
Although an exact interpretation of relatedness of isolates 
from humans to animals is not possible, the isolates cannot 
be regarded as distinct populations. Further characterization 
by MLST confi rmed that the genetic backbone of bovine 
and human E. coli O26 strains in Scotland match and that 
isolates from cattle in Scotland are closely related to highly 
pathogenic isolates from humans in Germany and Italy.
Characterization of human strains from Scotland and 
continental Europe and of bovine strains from Scotland 
showed that most E. coli O26 strains were ST29 and were 
likely to be capable of expressing a T3S system because they 
were eae and sepL positive. Although less virulent strains 
generally are present in cattle in Scotland, the unexpected 
fi nding of this study was that the genetic background of 
many of the strains shows a close relationship to strains 
causing severe human infections in continental Europe.
The use of NMS enables identifi cation of an association 
between HUS and ST21 strains and confi rms the role of stx2 
alone in severe human disease. As previously suggested, 
the hlyA gene was not associated with HUS (8). Our results 
indicate that, in addition to stx2, tccP2 is linked to the 
severity of clinical disease. Therefore, the risk to humans 
in Scotland from isolates from cattle might be even lower 
for E. coli O26 if ST21 and the carriage of tccP2 are 
considered.
In the absence of stx genes, isolates from cattle feces 
are less of a threat to human health than E. coli O157 strains, 
but there are E. coli O26 in Scotland of ST21 that are LEE 
positive and carry tccP2. These need only to acquire the 
stx2-encoding bacteriophage and they could prove to be 
highly pathogenic because E. coli O26 is a highly dynamic 
group capable of acquiring stx-encoding phages (34,35). 
Zhang et al. (14) described a shift in stx genotype from stx1 
to stx2: before 1994, only the stx1 gene was identifi ed in 
their STEC O26 isolate collection, but after 1997, stx2 was 
the only genotype identifi ed in 71% of the isolates. The 
trigger for this shift was not established.
At the time of our study, there was no correlation 
between farms in Scotland with E. coli O157 and E. coli 
O26 (p = 0.28) or those with E. coli O26 stx1+ stx2+ and E. 
coli O157 (p = 0.10). However, release of free stx-encoding 
bacteriophages into the intestinal environment (36,37) by 
STEC O157 or other EHEC may permit horizontal transfer 
of virulence genes to E. coli O26. Acquisition of stx2-
encoding bacteriophages could confer E. coli O26 with 
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Figure 3. Patterns in data associated with the clinical severity of 
Escherichia coli O26 infection in humans, as identifi ed by nonmetric 
multidimensional scaling, Scotland. A) Joint graph illustrating the 
association between the multilocus sequence typing and genotypic 
variables measured and the severity of the human infection 
(hemolytic uremic syndrome [HUS] in red and non-HUS [diarrhea, 
bloody diarrhea] in green). B) 3-dimensional scatterplot and 80% 
confi dence ellipses (R rgl package [33]) around the cases in space 
illustrating the separation between individual classes as HUS (red) 
and non-HUS (green).
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greater pathogenic potential for humans, and possession of 
stx2 may alter the bovine immune response and lead to longer 
shedding and to larger quantities of the shed bacterium, 
resulting in greater exposure to humans. Changes in 
virulence characteristics of strains may also affect pathogen 
transmission in cattle (38) and thus pose a greater threat to 
humans from an increase in bacterial prevalence.
We suggest that limited human exposure in Scotland 
to E. coli O26 with virulence genes explains the recorded 
difference in the number of human infections attributed to 
E. coli O26 or E. coli O157. In addition, the more virulent 
forms of E. coli O26 (stx2+eae+) in cattle in Scotland 
were clustered in the sparsely populated northeast region. 
However, exposure routes and exposure doses for E. 
coli O26 and serogroup O157 may differ, although no 
evidence confi rms this alternative explanation for the 
human infection rate differences. Although cattle are 
hypothesized as a potential reservoir of E. coli O26 (18), 
little is known about the transmission routes to humans and 
the only evidence linking human infection with cattle is 2 
HUS cases in Austria indirectly linked to consumption of 
unpasteurized milk (20).
The approach to laboratory diagnosis of non-O157 E. 
coli gastrointestinal infection in humans has changed in 
recent years. At the time of this study, testing of samples 
from humans for non-O157 E. coli was conducted by a 
small number of clinical diagnostic laboratories by using 
polyvalent antiserum. E. coli O26 isolates were forwarded 
to the SERL for virulence typing by PCR. SERL identifi ed 
additional E. coli O26 isolates by testing feces from patients 
with suspected STEC infection but who had negative 
routine culture results. However, since 2006–2007, 
non-O157 STEC detection in submitted fecal samples has 
been conducted solely by SERL by using PCR followed 
by culture and characterization of STEC. Since 2006–
2007, the reported incidence of E. coli O26 in Scotland has 
increased from 1.6% of all STEC identifi ed at SERL to 6% 
in 2010–2011 (Figure 5). The virulence patterns of E. coli 
O26 strains isolated from humans in Scotland also appear 
to have altered. The stx1+ E. coli O26 isolates previously 
predominated, but in 2010–2011, >50% of E. coli O26 
isolates possessed both stx1 and stx2, and for the fi rst time, 1 
isolate from human feces was solely positive for stx2.
In 2010, three particularly severe sporadic cases of 
HUS associated with E. coli O26 in children were reported 
in Scotland (39). The characteristics of 2 of the E. coli 
O26 strains included stx1 and stx2 (39). To our knowledge, 
this was the fi rst time >1 E. coli O26–attributed HUS case 
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Figure 4. Schematic comparing farm-level (A) and animal-level (B) prevalences of Escherichia coli O157 and E. coli O26 in Scotland for 
different virulence levels. Analysis was done by using only the 338 farms sampled for both E. coli O157 and E. coli O26. 
Pathogenic Potential of E. coli O26
was reported in Scotland in a calendar year, reinforcing 
Bettelheim’s (40) warning that we ignore these strains 
at our peril. Worldwide, reports of human outbreaks of 
non-O157 EHEC, including E. coli O26, are common 
(2). In addition, the recent outbreak of E. coli O104:H4 in 
Germany highlights the potential for Shiga toxin prophage 
acquisition into different E. coli genetic backgrounds with 
serious consequences for human health (3).
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